Retracted: First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Author:

Satouchi Miyako1ORCID,Nosaki Kaname2,Takahashi Toshiaki3,Nakagawa Kazuhiko4,Aoe Keisuke5,Kurata Takayasu6,Sekine Akimasa7,Horiike Atsushi8,Fukuhara Tatsuro9,Sugawara Shunichi10ORCID,Umemura Shigeki11,Saka Hideo12,Okamoto Isamu13ORCID,Yamamoto Nobuyuki14,Sakai Hiroshi15,Kishi Kazuma16,Katakami Nobuyuki17,Horinouchi Hidehito18ORCID,Hida Toyoaki19ORCID,Okamoto Hiroaki20,Atagi Shinji21,Ohira Tatsuo22,Han Shi Rong23,Noguchi Kazuo23,Ebiana Victoria24,Hotta Katsuyuki25ORCID

Affiliation:

1. Department of Thoracic Oncology Hyogo Cancer Center Akashi Japan

2. Department of Thoracic Oncology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

3. Division of Thoracic Oncology Shizuoka Cancer Center Shuntougun Japan

4. Department of Medical Oncology Kindai University Faculty of Medicine Osaka‐Sayama Japan

5. Department of Medical Oncology National Hospital Organization Yamaguchi Ube Medical Center Ube Japan

6. Department of Thoracic Oncology Kansai Medical University Osaka Japan

7. Department of Respiratory Medicine Kanagawa Cardiovascular and Respiratory Center Kanagawa Japan

8. Department of Thoracic Medical Oncology The Cancer Institute Hospital of the Japanese Foundation for Cancer Research Tokyo Japan

9. Department of Respiratory Medicine Miyagi Cancer Center Natori Japan

10. Department of Pulmonary Medicine Sendai Kousei Hospital Miyagi Japan

11. Department of Thoracic Oncology National Cancer Center Hospital East Kashiwa Japan

12. Department of Respiratory Medicine and Medical Oncology National Hospital Organization Nagoya Medical Center Nagoya Japan

13. Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University Fukuoka Japan

14. Internal Medicine III Wakayama Medical University Wakayama Japan

15. Department of Thoracic Oncology Saitama Cancer Center Saitama Japan

16. Department of Respiratory Medicine, Respiratory Center Totanomon Hospital Tokyo Japan

17. Division of Integrated Oncology Institute of Biomedical Research and Innovation Hospital Kobe Japan

18. Department of Thoracic Oncology National Cancer Center Hospital Tokyo Japan

19. Department of Thoracic Oncology Aichi Cancer Center Aichi Japan

20. Department of Respiratory Medicine and Medical Oncology Yokohama Municipal Citizen’s Hospital Yokohama Japan

21. Department of Thoracic Oncology National Hospital Organization Kinki‐Chuo Chest Medical Center Sakai Japan

22. Department of Surgery Tokyo Medical University Tokyo Japan

23. MSD K.K. Tokyo Japan

24. Merck & Co., Inc. Kenilworth NJ USA

25. Center for Innovative Clinical Medicine Okayama University Hospital Okayama Japan

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference20 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Japan Lung Cancer Society.Guidelines for lung cancer clinical practice 2018 edition: Non‐small cell lung cancer;2018.https://www.haigan.gr.jp/guideline/2018/1/2/180102070100.html#j_7‐2_1. Accessed January 11 2019

3. First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review

4. National Comprehensive Cancer Network (NCCN).NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non‐small cell lung cancer version 5.2019;2019.www.nccn.org. Accessed June 12 2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3